Revenues at Rs 12.6bn were down 13%yoy, due to lower than estimated fertilizer sales volumes and lower than estimated chemical segment revenues
EBITDA at Rs 939mn (adjusted for EO of Rs 473mn) was down 34%yoy lower than our estimates. Increase in gas cost and ammonia cost impacted EBITDA margin which stood at 7.4%, lower than our estimates of 12.5%
Benzene caprolactam spread for Q3FY15 averaged at $980/tonne vs $920/tonne in Q2FY15.,With sharp correction in benzene prices, the spreads have since increased to ~$1,050/tonne currently
We have reduced our FY15E revenue and earnings estimates lower by 7% and 17% respectively while we continue to maintain our FY16E. We continue to maintain our Buy rating on the stock with a target price of Rs140
"We have reduced our FY15E earnings lower by 17% driven by weaker than estimated Q3FY15 results. We though continue to maintain our FY16E on the back of overall improvement in demand for the complex fertilizer business and improving capro-benzene spreads. We continue to maintain our Buy rating on the stock with a target price of Rs 140", says Emkay Global Financial Services research report.
For all recommendations, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.